Pheochromocytoma and Paraganglioma: Genetic Testing for Patients and Families

Описание: Paraganglioma and phaeochromocytoma are rare tumors originating from hormone-producing cells, with up to 40% of cases linked to hereditary genetic mutations. Genetic testing is recommended for all patients to identify key genes like SDHx, VHL, RET, and NF1, which predict tumor behavior, malignancy risk, and guide personalized surveillance and treatment. This approach also facilitates cascade screening for family members, enabling early detection and improved outcomes.

This content is entirely based on medical research and evidence. Content carefully curated by Mr Saboor Khan FRCS FACS, PhD, Consultant Surgeon.

00:00 Introduction
00:51 Number One: Why Genetics Matter So Much in These Tumours
01:41 Number Two: How Your Genes Predict Tumour Behavior and Malignancy Risk
02:41 Number Three: Why Every Patient Should Have Genetic Testing
03:40 Number Four: What Genetic Testing Means for Your Family
04:21 Number Five: How Genetic Results Guide Treatment and Surveillance
05:13 Action Section
05:38 Conclusion

Explore the full video series for a broader understanding of your condition with evidence-based content — check out the playlist.

This content is for educational purposes only. Personal medical decisions must be made with your treating team. Patients should not draw inferences about their own condition from this content. Every effort is made to ensure content is current at time of production; however, this cannot be guaranteed.